MENU
CADL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Candel Therapeutics (CADL) Ownership - Who owns Candel Therapeutics?

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer... Show more

Profile

Industry
N/A
Address
117 Kendrick Street
Phone
+1 617 916-5445
Employees
55
Web
https://www.candeltx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
617.67M
P/E Ratio
N/A
Total Cash
194.83M
Projected Growth
N/A
Total Debt
49.27M
Revenue
N/A
Risk (Beta)
-3.08
Dividend Yield
N/A
Total Cash/Share
2.66
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
CADL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
117 Kendrick Street
Phone
+1 617 916-5445
Employees
55
Web
https://www.candeltx.com